Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
4.770
+0.740 (18.36%)
At close: Oct 9, 2025, 4:00 PM EDT
5.00
+0.23 (4.82%)
After-hours: Oct 9, 2025, 7:59 PM EDT
Pomdoctor Revenue
In the year 2024, Pomdoctor had annual revenue of 342.56M CNY with 12.37% growth. Pomdoctor had revenue of 192.39M in the half year ending December 31, 2024, with 41.85% growth.
Revenue (ttm)
342.56M CNY
Revenue Growth
+12.37%
P/S Ratio
3.85
Revenue / Employee
2,195,884 CNY
Employees
156
Market Cap
564.97M undefined
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 342.56M | 37.70M | 12.37% |
| Dec 31, 2023 | 304.85M | 59.64M | 24.32% |
| Dec 31, 2022 | 245.22M | 29.83M | 13.85% |
| Dec 31, 2021 | 215.38M | 74.18M | 52.53% |
| Dec 31, 2020 | 141.21M | -44.33M | -23.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
POM News
- 8 hours ago - POMDOCTOR LIMITED Announces Closing of Initial Public Offering - PRNewsWire
- 1 day ago - POMDOCTOR LIMITED Announces Pricing of Initial Public Offering - PRNewsWire
- 2 months ago - PomDoctor Files For Nasdaq IPO That May Be Overvalued - Benzinga
- 7 months ago - PomDoctor Begins $15 Million U.S. IPO Rollout - Seeking Alpha
- 7 months ago - Chinese online medical platform PomDoctor files for a $15 million US IPO - Renaissance Capital
- 7 months ago - Pomdoctor IPO Registration Document (F-1) - SEC